Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.92%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 5.87Close
$ 5.02 - $ 21.59 52-Week Range
Ticker Information
Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTRADA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TRDA - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 3.91M | 4.92% | $ 79.48M |
| 3/31/2025 | $ 3.79M | 2.2% | $ 172.22M |
| 12/31/2024 | $ 3.77M | 1.79% | $ 210.78M |
| 9/30/2024 | $ 3.52M | 1.63% | $ 215.23M |
| 6/30/2024 | $ 3.41M | 1.43% | $ 239.4M |
| 3/31/2024 | $ 3.23M | 1.99% | $ 162.87M |
| 12/31/2023 | $ 2.84M | 2.2% | $ 129.01M |
| 9/30/2023 | $ 2.63M | 3.02% | $ 87.17M |
| 6/30/2023 | $ 2.31M | 5.32% | $ 43.43M |
| 3/31/2023 | $ 2.05M | 8.1% | $ 25.26M |
Key Performance Insights, Last 5 Years
- ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 0%.
- Over the past 5 years, ENTRADA THERAPEUTICS INC's average DepAmor % has been 3.26%.
- The median DepAmor % for ENTRADA THERAPEUTICS INC during this period was 2.2%
- ENTRADA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 8.1%.
- The lowest DepAmor % recorded by ENTRADA THERAPEUTICS INC in the same timeframe 1.43%
ENTRADA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ENTRADA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 326K ] / Revenues [ $ 0 ]
(=) DepAmor % [ 0% ] TRDA - Depreciation and Amortization Margin, Last 5 years
1.43%
Minimum
Jun 30, 2024
8.1%
Maximum
Mar 31, 2023
3.26%
Average
2.2%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |